Guided Poster Tour

Posters and Information Guided Poster Tour

Here you can find all the details for the guided poster tour on Wednesday, 20.11.2024 from 19.00h - 20.30h in Hall 4.0.

Poster Station 1 - Hemostasis, transfusion medicine, vascular, laboratory medicine, benign hematology

Chairs: Patrick Bättig & Mathilde Gavillet

Poster 1: Sequential combinations of rapid immunoassays for prompt recognition of heparin-induced thrombocytopenia: a prospective validation study - T. Steinauer

Poster 2: Daratumumab for Refractory and Frequently Relapsing Immune Thrombotic Thrombocytopenic Purpura – a Case Series with Long-Term Follow-up - R. Schimmer

Poster 3: Modification of fibrinolytic potential after cessation of combined hormonal contraceptives - L. Olivier

Poster 4: Appearance of isoagglutinins after minor ABO-incompatible allogeneic stem cell transplants - B. Bours

Poster 5: Parameters impacting fibrinolysis in patients with liver cirrhosis - L.A. Gautier

Poster 6: Dengue fever mimicking plasma cell leukemia - A case series of patients with recently diagnosed dengue fever - L. Schmied

Poster 7: Disease Phenotype in Northeastern Thailand Patients with JAK2V617F-Positive - K. Chootawiriyasakul

Poster 8: First real-world case report of danicopan as an add-on therapy in a patient with paroxysmal nocturnal haemoglobinuria in Switzerland - G. Georgiou

Poster 9: An interesting case of concomitant anemia secondary to prolonged PARP inhibitor toxicity, and a hemolytic anemia with non-specific warm autoantibodies - J. Dereme

Poster Station 2 - Clinical hemato-oncology

Chairs: Thomas Lehmann & Fatime Krasniqi

Poster 1: High iASPP (PPP1R13L) expression is an independent predictor for adverse clinical outcome in acute myeloid leukemia (AML) - M. Schittenhelm

Poster 2: Idecabtagene vicleucel (ide-cel) shows similar efficacy and toxicity in patients with multiple myeloma aged 70 and older compared to younger patients: A multicenter cohort study - E. Shumilov

Poster 3: Reducing autophagy potentiates the restoration of MHC-I genes in Germinal B-cell Diffuse Large B-cell lymphomas - H. Mandhair

Poster 4: The cost-effectiveness of Axicabtagene Ciloleucel versus standard of care as second-line therapy in patients with large B-cell lymphoma in Switzerland - A. Gemlik

Poster 5: Utility of the 2024 best practice recommendations from the EBMT Cellular Therapy and Immunobiology Working Party for use of donor lymphocyte infusions after allogeneic haematopoietic stem cell transplantation - A.-C. Mamez

Poster 6: Comparative effectiveness of tyrosine kinase inhibitors (TKI) and blinatumomab versus TKI and chemotherapy in Philadelphia-positive acute B-lymphoblastic leukemia - M. Rieger

Poster 7: Early and long-lasting alteration of naive CD45RA(+) Foxp3(low) regulatory T-cell reconstitution after allogeneic hematopoietic stem cell transplantation - A. Ducrot

Poster 8: Are there non-hematological causes of hyperleukocytosis? Hyperleucocytosis cases in a tertiary university hospital over 10 years - E. Moutzouri

Poster 9: Older patients with non-Hodgkin Lymphoma receive as much treatment lines as younger ones through adjustment, in a real life setting - K. Nasrinfar

Poster 10: 10-year retrospective study on 5-azacitidine, 5-day 100mg/m2 schedule, as monotherapy for MDS and MDS/MPN (AZA-CHUV study) - G. Tsilimidos

Poster 11: Prognostic value of the new AML60+ score for elderly patients with acute myeloid leukemia (AML) treated with hypomethylating agents - T. Silzle

Poster Station 3 - Experimental hematology / oncology

Chairs: Heinz Läubli & Federico Simonetta

Poster 1: Differential MAPK Pathway Targeting for Improved Therapeutic Efficacy in Myeloproliferative Neoplasms - S. Arunasalam

Poster 2: Expression of KITD814V in murine hematopoietic stem cells results in an advanced systemic mastocytosis phenotype with associated myeloid neoplasm - S. Stivala

Poster 3: Targeting the SHP2 phosphatase enhances therapeutic effects of the JAK2 inhibitor ruxolitinib in myeloproliferative neoplasms by inhibiting the MAPK pathway - S. Hallenberger-Jungius

Poster 4: CD19 CAR T Cells drive a remodeling of the Immune Microenvironment associated with T-cell dysfunction in B-Cell Acute Lymphoblastic Leukemia - M. Ponzo

Poster 5: Enhancing CD117 directed bispecific T-cell engagers and activators by CD33 target-selective co-stimulation - M. Hofstetter

Poster 6: Ribonuclease Inhibitor (RNH1) is a Novel Regulator in Myelopoiesis and Resolves Differentiation Blockade in Acute Myeloid Leukaemia - D. Saha

Poster 7: Proteomic characterization of the blood-tissue interface of pre-metastatic lung and liver - L. Angenendt

Poster 8: Role of ERK1/2 kinases for thrombopoiesis and platelet function in myeloproliferative neoplasms - C. Albrecht

Poster 9: Single Cell Multi-Omic Correlation of Single Nucleotide Variants, Copy Number Variation and Surface Epitopes for Clonal Profiling of Myeloma - G. Papoutsoglou

Poster 10: Ribosome profiling defines the translational sequelae of proteasome inhibition in multiple myeloma - M. Román-Trufero

Poster 11: Patient-derived lymphomoids preserve the tumor architecture and allow testing response to therapies in lymphoma - J. Epiney

Poster 12: Molecular mechanisms of regulation of apoptosis and autophagy in pediatric Immune Thrombocytopenia - C. Bitsina

Poster 13: A NOVEL SINGLE-CELL MEASURABLE RESIDUAL DISEASE (SCMRD) ASSAY FOR SIMULTANEOUS DNA MUTATION AND SURFACE IMMUNOPHENOTYPE PROFILING - S. Colinet

Poster 14: The effects of released exosomes from stimulated NK-Cells with IL15 on the apoptosis of human acute myeloid leukemia cell line (HL-60) - S. Abbasi

Poster Station 4 - Clinical solid tumor oncology

Chairs: Kathrin Vollmer & Eugenio Fernandez

Poster 1: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer - T. Mehra

Poster 2: Integrating AI into Swiss Primary Care to Strengthen Medical Excellence - E. Camarillo-Retamosa

Poster 3: Co-alterations impacting first-line treatment in PD-L1 high KRAS G12C mutated lung adenocarcinoma in Real World Data within the Precision-Oncology-Program - R. Rahimzadeh

Poster 4: KEAP1/STK1/KRAS co-Alterations promote central nervous system (CNS) metastasis in Lung Adenocarcinoma and are associated with primary therapy resistance - L. Hempel

Poster 5: AI Driven Application in Digital Pathology for Breast Cancer Risk Prediction: A Swiss Retrospective Cohort Study - E. D. Chiru

Poster 6: Dynamic electronic reporting of treatment related symptoms (ePROs) can reversely identify the type of underlying cancer - A. Trojan

Poster 7: Interim results from the AVENUE study: real-world patient characteristics and safety with avelumab maintenance treatment for locally advanced/metastatic urothelial carcinoma - D. Zihler

Poster 8: General Practitioners' and Urologists' Perspectives on Organised Prostate Cancer Screening in Switzerland: A Cross-Sectional Online Survey - D. Menges

Poster 10: Outcomes and Disparities in Lung Cancer: Insights from a Real- World Registry before, during and a@er the COVID-19 pandemic - D. Kupka

Poster 11: Cost-Effectiveness of Biomarker Testing Among Early-Stage Breast Cancer Patients in Switzerland - C. Kurzeder

Poster 12: Neoadjuvant immunotherapy for stage III melanoma - the cohort study of a large swiss hospital - R. Zachariah

Poster 13: Transforming Precision Diagnostics of Switzerland: Applying Whole Genome and Transcriptome Data for Improved Patient Outcomes in Cancer Care - R. Nienhold

Poster 14: Targeted Therapies in ROS1-Mutated NSCLC: Long-Term Efficacy and Renal Cyst Formation with Crizotinib and Entrectinib - A. Fengler

Poster Station 5 - Nursing, supportive & palliative care, rehabilitation & survivorship

Chairs: Caroline Hertler & Andreas Jakob & Marika Bana

Poster 1: Cancer-related fatigue (CrF) – Incidence, predictive factors and treatment effects during oncological indoor rehabilitation - H.G. Hass

Poster 2: Enhancing Cancer Care: Implementation of Nurse-Led Consultations (NLC) in Oncology for Improved Patient experience" - R. von Moos

Poster 3: PROMs, quality of life and treatment effects during oncological indoor rehabilitation – analysis of 1230 cases - H.G. Hass

Poster 4: Nurse-Led Consultations (NLC) in Oncology: Financial Impact and Productivity Gains - R. von Moos

Poster 5: Influence of HCP Supervision on Quality-of-Life Questionnaire (QLQ) Scoring by Cancer Patients (Pts): A Prospective, Randomized, Cross-over Study (IMSUP). - D. P. de Jong-Bakker

Poster 6: Project Cancer Move Continuum Schweiz - N. Greco